JPRN-UMIN000026319
Not yet recruiting
未知
The intervention trial of safety and efficacy of once-weekly Trelagliptin switched from daily DPP4 inhibitors for elderly patients with type 2 diabetes - Safety and efficacy of Trelagliptin in elderly patients with type 2 diabetes
Kanagawa-ken Keiyu-kai Keiyu hospital0 sites30 target enrollmentMarch 1, 2017
ConditionsType 2 diabetes
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Type 2 diabetes
- Sponsor
- Kanagawa-ken Keiyu-kai Keiyu hospital
- Enrollment
- 30
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with renal dysfunction \[creatinine clearance \<50 ml/min or serum creatinine above 1\.4 mg/dl(male), 1\.2 mg/dl(female)] Patients using insulin or GLP\-1 receptor agonists
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A clinical study of the Safety and effectiveness of Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) treatment for the palliation of painful bone metastasesJPRN-UMIN000012441Department of Orthopaedic Surgery, Kochi Medical School, Kochi University25
Active, not recruiting
Phase 1
A randomized study of the efficacy and safety of OncoGel™ treatment as an adjunctive therapy to systemic chemotherapy and concurrent external beam radiation prior to surgery in subjects with localized or loco-regional esophageal cancerlocalized or loco-regional esophageal cancerMedDRA version: 9.1Level: LLTClassification code 10015362Term: Esophageal cancerEUCTR2007-005051-42-BEProtherics Salt Lake City, Inc124
Active, not recruiting
Not Applicable
A randomized study of the efficacy and safety of OncoGel™ treatment as an adjunctive therapy to systemic chemotherapy and concurrent external beam radiation prior to surgery in subjects with localized or loco-regional esophageal cancerlocalized or loco-regional esophageal cancerMedDRA version: 9.1Level: LLTClassification code 10015362Term: Esophageal cancerEUCTR2007-005051-42-CZProtherics Salt Lake City, Inc156
Unknown
Phase 3
Clinical study to assess the efficacy and safety of TA-650 in patients with active ulcerative colitisJPRN-jRCT2080220293Mitsubishi Tanabe Pharma Corporation
Completed
Phase 3
Clinical Trial of S-Amlodipine , Olmesartan and Hydrochlorothiazide combination tablet in the treatment of HypertensioCTRI/2011/06/001820Emcure Pharmaceuticals Ltd Pune200